Credit Suisse’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.23M Buy
11,237
+218
+2% +$22K ﹤0.01% 2141
2023
Q4
$1.15M Buy
11,019
+842
+8% +$82.1K ﹤0.01% 2247
2023
Q3
$1.07M Sell
10,177
-237
-2% -$30.4K ﹤0.01% 2257
2023
Q2
$1.34M Buy
10,414
+581
+6% +$88.5K ﹤0.01% 2192
2023
Q1
$1.72M Buy
9,833
+669
+7% +$120K ﹤0.01% 1972
2022
Q4
$1.52M Buy
9,164
+1,638
+22% +$257K ﹤0.01% 2041
2022
Q3
$1.06M Buy
7,526
+138
+2% +$25.2K ﹤0.01% 2292
2022
Q2
$1.51M Buy
7,388
+2,902
+65% +$635K ﹤0.01% 2102
2022
Q1
$1.14M Buy
4,486
+58
+1% +$15.8K ﹤0.01% 2459
2021
Q4
$1.45M Buy
4,428
+337
+8% +$106K ﹤0.01% 3034
2021
Q3
$1.24M Sell
4,091
-497
-11% -$141K ﹤0.01% 3168
2021
Q2
$1.25M Buy
4,588
+14
+0.3% +$3.55K ﹤0.01% 3217
2021
Q1
$1.11M Sell
4,574
-299
-6% -$82.3K ﹤0.01% 3255
2020
Q4
$1.4M Buy
4,873
+1,212
+33% +$333K ﹤0.01% 3091
2020
Q3
$932K Buy
3,661
+351
+11% +$83.4K ﹤0.01% 2982
2020
Q2
$718K Buy
3,310
+691
+26% +$159K ﹤0.01% 3110
2020
Q1
$592K Sell
2,619
-735
-22% -$181K ﹤0.01% 3008
2019
Q4
$837K Buy
3,354
+430
+15% +$101K ﹤0.01% 3253
2019
Q3
$694K Buy
2,924
+203
+7% +$46.9K ﹤0.01% 3238
2019
Q2
$664K Sell
2,721
-5,748
-68% -$1.34M ﹤0.01% 3228
2019
Q1
$1.95M Buy
8,469
+3,679
+77% +$832K ﹤0.01% 2388
2018
Q4
$997K Buy
4,790
+2,534
+112% +$494K ﹤0.01% 2776
2018
Q3
$419K Sell
2,256
-931
-29% -$187K ﹤0.01% 3391
2018
Q2
$672K Sell
3,187
-344
-10% -$60.2K ﹤0.01% 3279
2018
Q1
$524K Buy
3,531
+519
+17% +$70.8K ﹤0.01% 3337
2017
Q4
$375K Sell
3,012
-1,858
-38% -$260K ﹤0.01% 3548
2017
Q3
$727K Buy
4,870
+2,634
+118% +$372K ﹤0.01% 3313
2017
Q2
$320K Buy
2,236
+88
+4% +$12.5K ﹤0.01% 3418
2017
Q1
$264K Sell
2,148
-1,387
-39% -$170K ﹤0.01% 3561
2016
Q4
$433K Buy
+3,535
New +$441K ﹤0.01% 3517
2016
Q3
Sell
-3,834
Closed -$472K 4197
2016
Q2
$472K Buy
+3,834
New +$413K ﹤0.01% 3455
2016
Q1
Sell
-9,308
Closed -$925K 4177
2015
Q4
$925K Buy
9,308
+7,405
+389% +$792K ﹤0.01% 2876
2015
Q3
$212K Buy
+1,903
New +$201K ﹤0.01% 3901
2014
Q4
Sell
-5,093
Closed -$294K 4676
2014
Q3
$294K Buy
+5,093
New +$369K ﹤0.01% 3942
2014
Q2
Sell
-3,561
Closed -$322K 4738
2014
Q1
$322K Buy
3,561
+953
+37% +$81K ﹤0.01% 4042
2013
Q4
$205K Buy
+2,608
New +$190K ﹤0.01% 4317

Other funds holding MLAB

Credit Suisse's MLAB Position: Q1 2024 in Review

Credit Suisse increased its Mesa Laboratories (MLAB) stake by 2% in Q1 2024, buying an estimated $22K and bringing the position to 11,237 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Credit Suisse first reported a position in MLAB in Q4 2013 and has held it in 36 quarters since. The position peaked at $1.95M in Q1 2019. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.

  • Credit Suisse held 11,237 shares of Mesa Laboratories worth $1.23M as of Q1 2024.
  • Credit Suisse bought 218 Mesa Laboratories shares in Q1 2024, an estimated $22K.
  • Mesa Laboratories made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2141 holding.
  • Credit Suisse first reported a position in Mesa Laboratories in Q4 2013 and has held it in 36 quarters since.
  • Credit Suisse's Mesa Laboratories position peaked at $1.95M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.